期刊文献+

某院住院患者抑酸药物使用分析 被引量:3

Use Situation of Acid- Suppressive Drugs in Inpatients of a Hospital
下载PDF
导出
摘要 目的分析某医院住院患者抑酸药的应用情况,为临床合理用药提供参考。方法随机抽查该院2012年1月至12月期间住院患者抑酸药使用情况,统计抑酸药消耗数量、金额及科室分布,对用药频度、使用强度、抑酸药使用率、人均费用及适应证等进行统计和分析。结果住院患者抑酸药使用以质子泵抑制剂(PPI)占主导,主要采用静脉给药。内科使用频度占全院的71.75%,涉及消化、呼吸、心内、老年科等;外科占28.25%。住院患者使用率为37.24%,内科以消化、血液肿瘤、呼吸科使用率较高;外科以重症医学室(ICU)、脑外、肝胆等科室为主;人均费用200元以上。结论 PPI在ICU和非ICU患者中使用非常广泛,其使用方式和合理性值得探讨,有待规范。 Objective To analyze the use situation of acid-suppressive drugs in the inpatients so as to provide reference for the clini-cal rational use of drugs. Methods The random check on the use situation of acid-suppressive drugs in the inpatients was monthly conducted from January to June 2012, the consumption quantity, sales amount, department distribution, DDDs, use intensity, utilization rate of acid-suppressive medications, per capita costs and indications were performed the statistics analysis. Resuts In the acid-suppressive drugs use, the proton pump inhibitors ( PPI ) were predominant and mainly adopted the intravenous administration. The percentage of use frequency in internal medicine was 71. 75%, involving the digestion, respiration, cardiology, geriatrics, etc. Surgery was 28. 25%. The inpa-tient utilization rate was 37. 24%. In internal medicine, the digestive, hematological tumor and respiratory departments had the higher use rate of acid-suppressive drugs;surgery was dominated by critical care medicine, brain surgery and hepatobiliary departments. Per capita costs was over 200 Yuan. Conclusion PPI are very widely used in ICU and non-ICU patients, its use mode and rationality deserve to explore and need to be standardized.
出处 《中国药业》 CAS 2014年第17期62-64,共3页 China Pharmaceuticals
关键词 抑酸药 质子泵抑制剂 药物利用 合理用药 acid-suppressive drugs proton pump inhibitors drug utilization rational drug use
  • 相关文献

参考文献11

  • 1邹婷.质子泵抑制剂演绎精彩时刻·2007年16城市样本医院抗酸药及抗消化性溃疡用药分析[N].医药经济报,2008-08-18.
  • 2Joel J Heidelbaugh MD, John M Inadomi MD. Magnitude and Eco- nomic Impact of Inappropriate Use of Stress Ulcer Prophylaxis in Non- ICU Hospitalized Patients[J]. Am J Gastroenterol 2006,101: 2 200 - 2 205.
  • 3Patrick S Yaehimski MD MPH, Elizabeth A Farrell MD, Daniel P Hunt MD, et aL Proton Pump Inhibitors for Prophylaxis of Nosocomial Upper Gastrointestinal Tract Bleeding. Effect of Standardized Guidelines on Pre- scribing Practice[J] . (Reprinted) Arch Intern Med, 2010, 170(9): 779 - 783.
  • 4Steinberg K. Stress related mucosal disease in the critically illpatient: Risk factors and strategies to p revent stress - related bleedingin the inten- sive care unit[J]. Crit Care Med,2002,30: 362 - 364.
  • 5党国宏,刘治军.质子泵抑制剂与氯吡格雷药物相互作用研究进展[J].中国新药杂志,2012,21(7):751-756. 被引量:15
  • 6衣淑华,衣淑珍.质子泵抑制剂引发骨质疏松的病变机制和治疗策略[J].国际药学研究杂志,2012,39(1):61-64. 被引量:9
  • 7王晓虹,王瑜,胡良安.质子泵抑制剂和重症患者的医院获得性肺炎之间的关系[J].华西医学,2010,25(10):1811-1812. 被引量:10
  • 8Herzig SJ, Howell MD, Ngo LH, et al. Acid - suppressive medication use and the risk for hospital - acquired pneumonia [ J ] . JAJA, 2009,301 (20): 2 120 -2 128.
  • 9Gulmez SE, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community - acquired pneummonia : a population - based case - control study [ J ]. Arch Intern Med, 2007,167 (9) : 950 - 955.
  • 10金玲肖,刘福,龙惠珍,刘英超,郑华君,钟继红,江向红.应用质子泵抑制剂导致小肠细菌过度生长发生的可能性[J].中国微生态学杂志,2010,22(12):1113-1114. 被引量:11

二级参考文献47

  • 1郑家驹 龚正亮 等.氢气呼吸试验在胃肠病诊断中的应用[J].中华内科杂志,1985,24:240-242.
  • 2Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system[J]. Crit Care Med, 1985, 13(10):818 -829.
  • 3Herzig SJ, Howell MD, Ngo LH, et al. Acid-suppressive medication use and the risk for hospital-acquired pneumonia[J]. JAMA, 2009, 301(20):2120-2128.
  • 4Gulmez SE, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population based case-control study[J]. Arch Intern Med, 2007, 167(9):950- 955.
  • 5Leroy O, Soubrier S. Hospital-acquired pneumonia: risk factors, clinical features, management, and antibiotic resistance[J]. Curr Opin Pulm Med, 2004, 10(3) : 171-175.
  • 6FRIED M,SIEGRIST H,FREI R,et al. Duodenal Bacterial overgrowth during treatment in outpatients with Omeprazote [ J ]. GUT, 1994,35(1):23-26.
  • 7TILLMAN R, KING C, TOSKES P. Continued experience with the xylose breath test: Evidence that the mall bowel culture as a gold standard for bacterial overgrowth may be tarnished [ J ]. Gastroenterology, 1981,80(6) :1304.
  • 8PIMENTEL M, CHOW E J, LIN H C.. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome[ J ]. Am J Gastroenterol, 2000,95 ( 12 ) : 3503-3506.
  • 9KERLIN P, WONG L. Breath hydrogen testing in bacteria overgrowth of the small intestine[ J]. Gastroenterology, 1988,95 (4) :982.
  • 10Hill M J, Drasar BS. The normal colonic bacterial flora [J]. Gut, 1975,16 (4) :318-323.

共引文献53

同被引文献24

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部